Five drugs to watch as we close out 2021

OptumRx is pleased to provide a summary of five featured drugs that are expected to make an impact on patients and the market.

In this latest quarterly Drug Pipeline Insights Report, OptumRx showcases: 

• A treatment for moderate-to-severe plaque psoriasis
• A new therapy designed to help cancer patients tolerate their cancer fighting medication
• A new cellular based therapy for multiple myeloma
• An unusual pairing of the common over-the-counter cough suppressant with a standard antidepressant for treatment of adult patients with major depressive disorder
• A treatment for generalized myasthenia gravis, which is a neuromuscular disorder primarily characterized by muscle weakness and muscle fatigue

View report

Don't want to read the full report? Download the brief summary.

Download summary